Glucose and high-sensitivity troponin T predict a low risk of major adverse cardiac events in emergency department chest pain patients
Background Glucose is emerging as a biomarker for early and safe rule-out of acute myocardial infarction in emergency department (ED) chest pain patients. We evaluated the diagnostic accuracy of dual testing with high sensitivity TnT (hs-cTnT) and glucose for prediction of major adverse cardiac events (MACE) within 30 days. Methods This was a secondary analysis of…